Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank25
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-56.98M
↓ 21% vs avg
Percentile
P25
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-47.26M
Historical baseline
PeriodValueYoY Change
TTM$-56.98M-0.3%
2024$-56.83M-81.1%
2023$-31.39M+39.2%
2022$-51.66M+42.6%
2021$-89.94M-17.0%
2020$-76.85M-107.8%
2019$-36.98M-196.4%
2018$-12.48M-2.0%
2017$-12.23M-